Product Details:
| Strength | 200mg |
| Form | Capsules |
| Brand | Molnulee 200 |
| Manufacturer | John Lee pharmaceuticals pvt. ltd. |
| Packaging Size | 1*40 |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Composition | Molnupiravir 200 mg |
Molnupiravir is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death) or in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate.